Terkko Navigator / Grénman, R.

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).

Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.

The critical effects of matrices on cultured carcinoma cells: Human tumor-derived matrix promotes cell invasive properties.

Copy number gains of the putative CRKL oncogene in laryngeal squamous cell carcinoma result in strong nuclear expression of the protein and influence cell proliferation and migration.

Human Tumor-Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing.

PCR-based zebrafish model for personalised medicine in head and neck cancer.

Expression of Serpin Peptidase Inhibitor B2 (SERPINB2) is regulated by Aryl hydrocarbon receptor (AhR).

Non-curative treatment of patients with oral tongue squamous-cell carcinoma.

Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.

DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma.

Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association.

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

Downregulation of CEACAM6 gene expression in laryngeal squamous cell carcinoma is an effect of DNA hypermethylation and correlates with disease progression.

Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer.

Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.

Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma.

Drug sensitivity screening and genomic characterization of 45 HPV-negative head and neck carcinoma cell lines for novel biomarkers of drug efficacy.

Polyomaviruses detectable in head and neck carcinomas.

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma.

Single nucleotide polymorphism rs11614913 associated with CC genotype in miR-196a2 is overrepresented in laryngeal squamous cell carcinoma, but not salivary gland tumors in Polish population.

Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.

Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.

Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.

PWP1 Mediates Nutrient-Dependent Growth Control through Nucleolar Regulation of Ribosomal Gene Expression.

Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells.

Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors.

Outcome of nasopharyngeal carcinoma in Finland: A nationwide study.

Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.

Improved outcomes with oral tongue squamous cell carcinoma in Finland.

Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas.

Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.

Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.

The feasibility of NBI in patients with suspected upper airway lesions: A multicenter study.

Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.

Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies.

Investigation of the expression of RIF1 gene on head and neck, pancreatic and brain cancer and cancer stem cells.

Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.

Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription.

Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2.

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests.

Susceptibility of human tonsillar epithelial cells to enterovirus 71 with normal cytokine response.

Liprin-α1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery.

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.

Proteomic profiling identifies the inorganic pyrophosphatase (PPA1) protein as a potential biomarker of metastasis in laryngeal squamous cell carcinoma.

Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.

Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma.

Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.

MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.

Pretreatment microRNA expression impacting on epithelial to mesenchymal transition predicts intrinsic radiosensitivity in head and neck cancer celllines and patients.

[Laryngeal cancer in Finland].